טוען...
Drugs for hypercholesterolaemia – from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition
Cardiovascular disease (CVD) remains one of the commonest sources of morbidity and mortality in the world. Lipids and especially low density lipoprotein cholesterol (LDL-C) contribute to the risk of CVD events. Statins are the primary therapy for hypercholesterolaemia and recent evidence supports th...
שמור ב:
| הוצא לאור ב: | Clin Med (Lond) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Royal College of Physicians
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280202/ https://ncbi.nlm.nih.gov/pubmed/27481380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.16-4-353 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|